Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 CEO'S ADDRESS - LIBERATOR MEDICAL HOLDINGS, INC. | f8k091115_ex99z1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 11, 2015
LIBERATOR MEDICAL HOLDINGS, INC. |
(Exact name of registrant as specified in its charter) |
NEVADA | 000-05663 | 87-0267292 |
(State or other jurisdiction | (Commission | (IRS Employer |
Of incorporation) | File Number) | Identification Number) |
2979 SE Gran Park Way, Stuart, Florida 34997 |
(Address of Principal Executive Offices) |
|
(772) 287-2414 |
(Registrant’s telephone number, including area code) |
|
|
(Former name or former address, if changed since last report.) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
.
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
.
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
.
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
.
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07
Submission of Matters to a Vote of Security Holders
On September 11, 2015, Liberator Medical Holdings, Inc., a Nevada corporation (the “Company”), held its annual meeting of stockholders to (i) elect directors; and (ii) ratify the appointment of its independent registered public accounting firm. A majority of the stockholders entitled to vote at the annual meeting were present at the annual meeting in person or by proxy. The following table shows the number of votes cast for, against, abstentions, and the number of broker non-votes on each matter.
Election of Directors: | For | Against | Withheld | Broker Non-Vote |
Mark A. Libratore | 31,951,772 | 0 | 135,769 | 10,754,511 |
Jeannette Corbett | 31,315,758 | 0 | 771,783 | 10,754,511 |
Tyler Wick | 31,772,277 | 0 | 315,264 | 10,754,511 |
Ruben J. King-Shaw, Jr. | 31,719,198 | 0 | 368,343 | 10,754,511 |
Philip Sprinkle | 31,934,572 | 0 | 152,969 | 10,754,511 |
|
|
|
|
|
Ratification of Public Accountants: | For | Against | Abstain |
|
Crowe Horwath LLP | 42,555,834 | 263,120 | 23,098 |
|
|
|
|
|
|
Act upon such other business as may properly come before the Annual Meeting | For | Against | Abstain |
|
| 38,385,733 | 3,814,640 | 641,679 |
|
Item 8.01
Other Events
On September 11, 2015, Mark A. Libratore, the Company’s President and Chief Executive Officer, addressed the stockholders at the Company’s annual meeting of stockholders in Stuart, Florida. Mr. Libratore’s remarks are filed as Exhibit 99.1 to this Report on Form 8-K.
The information under this caption, “Item 8.01 – Other Events,” including information in any related exhibits, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section. This information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits
(d)
Exhibits
Exhibit No. |
| Description |
|
|
|
99.1 |
| Remarks of President and Chief Executive at the Company’s Annual Stockholders Meeting on September 11, 2015. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
LIBERATOR MEDICAL HOLDINGS, INC.
Registrant
Dated: September 11, 2015
/s/ Mark A. Libratore
Mark A. Libratore, President
3